Adaptin Bio, Inc. (APTN)
OTCMKTS · Delayed Price · Currency is USD
6.27
0.00 (0.00%)
Aug 10, 2026, 2:56 PM EDT
Adaptin Bio Market Cap
Adaptin Bio has a market cap or net worth of $56.4 million as of August 11, 2026.
Market Cap
56.40M
Enterprise Value
56.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.27
ChartMarket Cap Chart
Since May 14, 2026, Adaptin Bio's market cap has increased from 49.20M to 56.40M, an increase of 14.63%. That is a compound annual growth rate of 76.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 56.40M | - |
| Aug 3, 2026 | 56.40M | 0.32% |
| Jul 14, 2026 | 56.22M | 0.48% |
| Jul 9, 2026 | 55.95M | 0.39% |
| Jun 29, 2026 | 55.73M | 0.96% |
| Jun 18, 2026 | 55.20M | - |
| Jun 17, 2026 | 55.20M | 0.91% |
| Jun 9, 2026 | 54.70M | 3.00% |
| Jun 8, 2026 | 53.11M | - |
| Jun 3, 2026 | 53.11M | - |
| May 27, 2026 | 53.11M | - |
| May 20, 2026 | 53.11M | 7.94% |
| May 14, 2026 | 49.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HyOrc | 56.77M |
| Northeast Indiana Bancorp | 56.60M |
| MainStreetChamber Holdings | 56.25M |
| Centaur Media | 56.15M |
| Baker Boyer Bancorp | 55.96M |
| Cell Source | 55.94M |
| Infinity Bancorp | 55.89M |
| Veri Medtech Holdings | 55.73M |